IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Epirus Biopharmaceuticals in

CUSIP: 29428P907 | 3 institutional holders

Quarters

Q3 2016Q2 2016Q4 2015Q3 2015Q2 2015
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile